STAT

FEBRUARY 2, 2024

Apple Vision Pro, the company’s most important new product in a decade, promises to envelop consumers in an immersive world of interactive content while employing clever technologies to make the device more usable and less alienating than virtual reality headsets that have come before it. Marketing for Vision Pro has focused on the $3,499, 1.3-pound helmet’s potential for watching video, making work calls, viewing family photos, and other casual uses.

Hospitals 355

Hospitals 355

PharmaVoice

FEBRUARY 2, 2024

Explosive demand for weight loss drugs has propelled both companies to new heights. Here’s a look at the staggering growth, by the numbers.

264

264

STAT

FEBRUARY 2, 2024

The Food and Drug Administration should move more quickly to ensure pulse oximeters — the ubiquitous devices used to measure blood oxygen — work well in all patients, should better inform clinicians about the devices’ shortcomings in patients with darker skin, and should recall versions that are particularly problematic, patients, researchers, and consumer advocates testified during a public meeting on Friday.

362

362

ALiEM - Pharm Pearls

FEBRUARY 2, 2024

An 18-year-old-female with no known past medical history presented with a lesion on her back that had been present and enlarging for five months. It was not painful unless she touched it, and then only mildly tender. She denied any known cause, wound, prior rash, or other lesions. Her review of systems and past medical history were negative. Additional Images Physical Exam Vitals : Normal Skin : An erythematous lenticular, or biconvex, lesion with distinct borders is noted at the left posterior

169

169

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

FEBRUARY 2, 2024

Since the 1920s , lead vests and aprons have served as trusted shields against the harmful effects of X-rays for radiologists, technicians, and patients. But new safety guidelines  from the American Dental Association (ADA) call for discontinuing their use among patients, both because X-ray technology has evolved significantly over the years, and because there are better ways to reduce patients’ exposure to radiation, such as using digital as opposed to conventional X-ray film.

306

306

Pharmaceutical Commerce

FEBRUARY 2, 2024

A dive into this market reveals that the latest numbers yield promising results—a global value of a worldwide $1.6 trillion—but it will continue to be attributed to past, present, and future healthcare spending.

116

116

FDA Law Blog: Biosimilars

FEBRUARY 2, 2024

By Steven J. Gonzalez & Allyson B. Mullen — On January 31, 2024, FDA announced its intent to initiate the reclassification process for most in vitro diagnostic (IVD) products that are currently class III (high risk) into class II (moderate risk). Most of these reclassified tests will supposedly be infectious disease and companion diagnostic IVDs.

113

113

STAT

FEBRUARY 2, 2024

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund. The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

316

316

BioPharma Dive

FEBRUARY 2, 2024

The California biotech is the third this year to go public, following stock offerings from CG Oncology and Arrivent Biopharma.

Drug Development 128

Drug Development 128

STAT

FEBRUARY 2, 2024

Aduhelm, a pioneering treatment for Alzheimer’s disease that collapsed under corporate mistakes and regulatory controversy, is now a cautionary tale in pharmaceutical history. This week Biogen said it would no longer sell or study the medicine , which first won approval in 2021, ending an era for one of biotech’s storied companies and leaving the rest of the industry to piece together the lessons of a would-be blockbuster that never took off.

302

302

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Pharma Times

FEBRUARY 2, 2024

Dopamine neuron senescence is a hallmark of Parkinson’s disease

154

154

STAT

FEBRUARY 2, 2024

Myopia, or near-sightedness, is on the rise: Nearly half of the world’s population will be nearsighted by 2050,  according to the World Health Organization. The condition is increasingly common among children in particular, which ophthalmologists attribute to a combination of less time spent outdoors and more time spent with iPads and iPhones.

284

284

Express Pharma

FEBRUARY 2, 2024

Everybody is talking about the funding winter for startups. Do biotech startups have to worry about a funding winter? If yes, how do they prepare for it? How do they survive it? A funding winter for biotech startups is a concern. It has been there since the inception of biotech startups. However, there has been constant improvement in the funding scenario for these startups.

Vaccines 104

Vaccines 104

STAT

FEBRUARY 2, 2024

Chicago pediatric hospital Lurie Children’s has been forced to take its network offline in the face of a “cybersecurity matter” as experts warn of heightened threats against health systems across the country. Late Thursday, Lurie Children’s Hospital, which uses Epic System’s electronic health record software, said it was “actively responding” to the issue and working with experts and law enforcement.

Hospitals 285

Hospitals 285

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

European Pharmaceutical Review

FEBRUARY 2, 2024

Orano Med (a subsidiary of the Orano Group), has begun to build a new manufacturing site for targeted alpha therapies (TAT) for oncology indications. The ATLab (Alpha Therapy Laboratory) Valenciennes in Onnaing, France, will produce lead-212 radioligand therapies. TAT [targeted alpha therapies] is one of the most potent therapeutic payloads against cancer cells” According to Orano Med, TAT is “one of the most potent therapeutic payloads against cancer cells” As such, these trea

98

98

STAT

FEBRUARY 2, 2024

WASHINGTON — A bipartisan group of senators released a draft of legislation to resolve controversial disputes in the 340B drug discount program, according to documents obtained by STAT. The drug discount program, which was designed to support providers that serve low-income patients, has been increasingly contentious as it’s grown in recent years.

Documentation 246

Documentation Drug Pricing 246

European Pharmaceutical Review

FEBRUARY 2, 2024

A study has described a multivalent-colloid detection system capable of identifying whole genomes of bacteria without the use of DNA amplification. Data from the paper published in Applied Physical Sciences , showed that the method can detect pathogens at an early stage when the bacterial load is low. Currently, the “gold standard” of pathogen identification is based on the recognition of DNA sequences that are unique for a given pathogen, according to the authors.

98

98

STAT

FEBRUARY 2, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hey there. Today, we talk about how biomanufacturing is getting a huge boost in North Carolina, study a new potential root for autoimmune disease in women, and more.

Drug Pricing 234

Drug Pricing Drug Development 234

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

FEBRUARY 2, 2024

Learn more about Katherine Stueland, the CEO of GeneDx, as she discusses her journey, the future of diagnostics, whilst at JP Morgan 2024.

115

115

STAT

FEBRUARY 2, 2024

I’ve spent a good deal of my career thinking about how we structure and fund research in the biomedical sciences in the U.S. and questioning whether the U.S. model of embedding research in universities is the right one. So to me, the launch of Arena BioWorks is welcome news. As media reports have highlighted, the new effort — a press release says that it was “ inspired by the success of Bell Labs” — promises to let scientists engage in research without first ge

217

217

European Pharmaceutical Review

FEBRUARY 2, 2024

Biogen is planning to reprioritise its resources allocated to ADUHELM ® (aducanumab-avwa), to advance its Alzheimer’s treatment LEQEMBI ® (lecanemab-irmb) and to develop new treatment modalities. The company stated that it will discontinue the development and commercialisation of ADUHELM 100 mg/mL intravenous injection and will terminate the corresponding Phase III ENVISION clinical study.

97

97

STAT

FEBRUARY 2, 2024

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them.  Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

212

212

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

FEBRUARY 2, 2024

Our round-up of recent biotech financings is headed by a $250 million public offering for late clinical-stage biotech Vera Therapeutics, with an initial public offering (IPO) filed by CAR-T specialist Kyverna and private rounds for Eyconis, COUR Pharmaceuticals, Basking Biosciences, Enterprise Therapeutics, Halia Therapeutics and NeoPhore.

103

103

The Pharmacist

FEBRUARY 2, 2024

Pharmacy minister Dame Andrea Leadsom has faced criticism from the sector after she claimed that allowing community pharmacists to alter prescriptions and supply alternative medications could ‘exacerbate’ supply issues. Individual pharmacists would be operating ‘without the full oversight of supply issues that the [Department of Health and Social Care] has’, she suggested.

97

97

Express Pharma

FEBRUARY 2, 2024

The Indo-German Chamber of Commerce, in collaboration with ACHEMA, organised an event called, ‘Catalysts of Change: Navigating Industrial Growth and Sustainable Development’. Held at The President in Mumbai on January 30, 2024, this event served as a prelude to the ACHEMA 2024, a forum and platform for the process industries scheduled for June 2024 in Frankfurt, Germany.

94

94

The Pharmacist

FEBRUARY 2, 2024

The Medicines and Healthcare Regulatory Authority (MHRA) has issued new dispensary posters, patient cards and guidance for healthcare teams as changes to valproate regulations came into effect this week. The government body has also stressed the ‘vital role’ of pharmacists in ensuring patients are aware of the risks of valproate. As of Wednesday 31 January, […] The post Latest valproate information as new rules come into force appeared first on The Pharmacist.

92

92

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

FEBRUARY 2, 2024

Indian pharma Hikma has agreed a $150 million settlement to resolve lawsuits claiming that it helped fuel to the opioid crisis in the US

110

110

Pharma Times

FEBRUARY 2, 2024

Individuals with Jewish ancestry are six times more likely to carry a genetic fault

120

120

pharmaphorum

FEBRUARY 2, 2024

The PM Society are delighted to be running their fifth Careers Conference that will be taking place on the 21st of February 2024 between 1pm to 6pm at the Royal Society of Medicine. Please share with your colleagues and network, as this is a great opportunity for students to attend and learn more about our industry.

96

96

PharmaTech

FEBRUARY 2, 2024

Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.

98

98

Pharmaceutical Commerce

FEBRUARY 2, 2024

Leading experts in the sector explore the value of third-party logistics providers when it comes to fortifying pharmaceutical supply chains.

94

94